Pershing Square
| Pershing Square
Company
Deck Type
Sector
Industry
Deck date
February 2021
Slide
44 of 57
Related slides by other companies
AstraZeneca
Results
November 2023
capital allocation capital allocation strategy unchanged investments to drive future growth reinvestment in the business free post currently projects in phase development investments behind launches in new indications and strengthening leadership in existing therapy areas continued investments in new technologies and platforms including cell and gene therapies progressive dividend policy value accretive deals continue to leverage partnerships to drive innovation and bring medicines to markets priority remains in our business new approvals in major markets | AstraZeneca
Lucid Motors
SPAC
July 2021
changing luxury market values traditional luxury post luxury | Lucid Motors
Nestle
Investor Conference
June 2023
growth by choice optimize portfolio rigorously | Nestle
Bakkt
Results
August 2022
summary of current environment | Bakkt
Other recent decks by Pershing Square
See all presentations (16 decks)
Investor Presentation
February 2025
Investor Presentation
February 2024
Investor Presentation
February 2023
Activist
February 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights